Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
The Henry J. Kaiser Family Foundation

Gates Foundation Backing Phase III Clinical Trial Of New TB Drug Regimen

News outlets report on the announcement of a Phase III clinical trial for a drug regimen that has the potential to fight drug-resistant tuberculosis. The Guardian: New and better treatments for drug-resistant tuberculosis on the horizon “A new trial of a novel drug combination that could dramatically shorten treatment for…

News Summary Read More
The Henry J. Kaiser Family Foundation

New Drug Regimen Aims To Transform TB Treatment, Improve Health

“The first-ever drug regimen designed to treat both drug-sensitive TB and MDR-TB [multidrug-resistant TB] has reached a critical milestone and will advance to a global Phase III clinical trial — the last, but most important stage of testing before it can be made available,” Mel Spigelman, president and CEO of…

News Summary Read More
The Henry J. Kaiser Family Foundation

Ebola Virus In West Africa Is New Strain, Study Says

News outlets reference a report published in the New England Journal of Medicine suggesting the Ebola virus in West Africa is a new strain. Associated Press: Ebola virus in Africa outbreak is a new strain “The Ebola virus that has killed scores of people in Guinea this year is a…

News Summary Read More
The Henry J. Kaiser Family Foundation

Children Receive Less Effective Diarrhea Care In Private Sub-Saharan African Hospitals

“Children in sub-Saharan Africa who suffer from diarrhea are receiving lifesaving treatment at a lower rate when visiting private hospitals as compared to public ones. Closing that gap would save an estimated 20,000 lives each year,” development blogger Tom Murphy writes in a post on Humanosphere. Murphy examines the findings…

News Summary Read More
The Henry J. Kaiser Family Foundation

Clinical Trials Of Hepatitis C Treatments Show Success

News outlets examine recently released clinical trial results of hepatitis C treatments. Financial Times: Drug groups step up race for hepatitis C treatments “Drugmakers are stepping up the race for multibillion-dollar hepatitis C treatments after trial data showed how the disease had become one of the most promising areas of…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S.-Funded Research On Ebola Treatments Shows Progress

CQ HealthBeat: U.S.-Funded Ebola Drugs Make Gains in Testing “While global health agencies confront the recent Ebola outbreak in western Africa, researchers funded by federal agencies are gaining ground in efforts to develop medicines to combat the deadly virus…” (Young, 4/11).

News Summary Read More
The Henry J. Kaiser Family Foundation

Study, Commentary Examine XDR-TB Treatment Outcomes In S. Africa

A post in the Center for Global Health Policy’s “Science Speaks” blog discusses a study and commentary published last week in The Lancet that evaluated the long-term outcomes of extensively drug-resistant tuberculosis (XDR-TB) patients in South Africa. “…Both the report and commentary call for policymakers and national control programs to…

News Summary Read More
The Henry J. Kaiser Family Foundation

Clinical Trial Of Drug To Prevent Excessive Bleeding After Childbirth Set To Begin

The Guardian: Drug to prevent excessive bleeding after childbirth could save thousands of lives “The trial of a new drug to prevent excessive bleeding in women after childbirth, which could potentially save thousands of lives annually, is to begin in 12 countries in June…” (Ford, 4/4).

News Summary Read More
The Henry J. Kaiser Family Foundation

USAID Launches U.S. Global Development Lab

Media sources report on USAID’s launch of its new U.S. Global Development Lab. Devex: USAID, Hillary Clinton launch Global Development Lab for game-changing innovations “The day is finally here. After four years in the works, multiple name changes, and numerous launch delays, the U.S. Agency for International Development is finally…

News Summary Read More
The Henry J. Kaiser Family Foundation

Senate Appropriators Committed To Biomedical Research Investment But Unsure Of Funding Source

CQ News: Appropriators Want to Boost NIH Funding, But No Source Apparent Yet “Top Senate appropriators said Wednesday that they are committed to investing in biomedical research at the National Institutes of Health, but the source for any additional funding for the agency remained elusive…” (Attias, 4/2).

News Summary Read More